IN FOCUS FEATURE
Biotechnology Center Gives Grant Writers a Boost
FROM OUR WEB SITE
Biotechnology Center Gives Grant Writers a Boost
To celebrate a new year, the Biotechnology Center is offering a new funding opportunity for people involved in the biosciences or related economic development who’d like to improve their grant-writing skills. These unique grants, of up to $5,000, will only be available this year.
To learn more about the Grantsmanship Training Grant and how to apply, read this week's In Focus.
From Our Web Site
PTRP Head to Chair NC Research Parks Group
Bill Dean, the director of the Piedmont Triad Research Park, has been named chairman of the newly formed North Carolina Research Parks Network organization, a coalition of seven leading science parks located across the state of North Carolina.
Liquidia Joins Abbott to Fight Cancer
Liquidia, an RTP nanotechnology spin-out from the University of North Carolina at Chapel Hill, has signed an agreement with Abbott to let the drug giant use Liquidia's PRINT nanotechnology to deliver cancer therapy.
Chimerix Drug Advances
Durham's Chimerix moved its lead anti-viral drug candidate into Phase II clinical trials after successful results in Phase I evaluation.
Join the NC Pavilion at BIO 2009
NC Commerce is offering sponsorship opportunities for this year's pavilion at BIO. For those interested, there will be a meeting at 10 a.m. on January 12 at the North Carolina Biotechnology Center.
PPD Buys Lab, Hires 80 from Merck
The new deal expands PPD's existing relationship with Merck for five more years.
Meda Adds $6M to BioDelivery
BioDelivery Sciences of Raleigh has collected $3 million in the sale of another round of marketing rights for its lead product, ONSOLIS. The deal allows BioDelivery's Swedish commercial partner, Meda, to sell the drug everywhere but Taiwan and South Korea.
K-12 Classroom Grant Program Accepting Applications
The Biotechnology Center's Biotechnology Mini-Grant program is accepting applications through noon on January 21. Visit the Mini-Grant page.
Novartis Pays $20M for AlphaVax Drug
Research Triangle Park's AlphaVax has sold rights to its experimental herpes vaccine to Swiss-based Novartis.
Durham Lands Sipcam HQ
Italian agriculture chemical firm Sipcam Agro moved its U.S. headquarters from Roswell, Georgia, to Durham effective January 5.
Next Safety to Sell Inhaler
Jefferson-based Next Safety plans to sell its inhaler drug-delivery technology through competitive bidding that will close on February 12.
Hamner Institutes Get $2.1M Grant
The Hamner Institutes in RTP has landed a $2.1 million EPA grant to study possible asbestos toxicity in vermiculite mined in Montana.
GSK Studies New Heart Drug
GlaxoSmithKline is making a big investment in a new type of drug for the heart disease market - it is starting a 15,000-patient, late-stage study of its experimental compound darapladib.
Three NC Firms Star at SE BIO
Three Triangle-area biotech firms take top prizes at Southeast BIO's 10th anniversary Investor Forum.
AlphaVax, Novartis Team on Herpes Vaccine
Each year, about 30,000 babies are born infected and about 8,000 of them develop permanent disabilities.
From the (Raleigh) News & Observer
Joe DeSimone - 2008 Tar Heel of the Year
The UNC-Chapel Hill researcher and professor was also the winner of the 2008 Lemelson-MIT Prize, which many consider a step to the Nobel.
From the (Raleigh) News & Observer
Liquidia Lands Drug Partnership
Durham-based Liquidia uses nanotechnology to find new ways to deliver medicine and for other purposes.
From the (Raleigh) News & Observer
PPD Buys Merck Vaccine-testing Lab
Under the collaboration, PPD will provide Merck development and testing services at the lab to support Merck's vaccine portfolio.
From the (Raleigh) News & Observer
Sipcam Agro heads to Durham; Italian agrochemical company is moving U.S. headquarters to Triangle
Five of the top eight agrochemical companies worldwide have U.S. headquarters or research facilities in the Triangle.
From the (Raleigh) News & Observer
From Local Tech Wire
Trana Discovery Offers New Approach to Fighting Infectious Disease
A biotech startup out of North Carolina State University and the Technical University of Lodz, Poland, has developed a new patented technology that may help defeat a wide range of infectious diseases, including antibiotic resistant staph and the wily AIDS virus.
From Tech Journal South
A new dimension for research
The Charlotte Business Journal interviews former Gov. Jim Martin about his appointment to the advisory board of the UNC Nutrition Research Institute.
From the Charlotte Business Journal
Community Watch
-
Danielle McCulloch has joined the Apex firm Fuentek as a consultant to evaluate intellectual property portfolios and assess opportunities for commercialization for university, government and corporate clients. More
February 16-17, 2009
Biotech 2009
(Raleigh)
May 13-14, 2009
Chapel Hill Drug Conference
(Chapel Hill)
May 18-21, 2009
BIO International Convention
NC Pavilion Sponsorship
(Atlanta)
View our complete listing of events across North Carolina.
This newsletter was sent Thursday, January 8, 2009. For the latest headlines from North Carolina’s biotechnology industry, please visit the news section of our Web site.
Online subscription management is now available. Please respond to this e-mail if you cannot change your preferences online.